Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

RAY1225

A Study of RAY1225 in Participants With Obesity

Guangdong Raynovent Biotech Co · Phase 2 · Recruiting · Enrollment 270

NCT06254261

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
RAY1225 (cohort 1)n/rn/rn/rn/r
Placebo (cohort 1)n/rn/rn/rn/r
RAY1225 (cohort 2)n/rn/rn/rn/r
Placebo (cohort 2)n/rn/rn/rn/r

Not shown

  • RAY1225 (cohort 1): endpoint not reported
  • Placebo (cohort 1): endpoint not reported
  • RAY1225 (cohort 2): endpoint not reported
  • Placebo (cohort 2): endpoint not reported